Opinion|Videos|June 9, 2023
Emerging Evidence on the Treatment of Obesity
In this episode of MEDcast, Diana Isaacs and Natalie Bellini interview Dr. Ken Fujioka, an endocrine specialist, to discuss practice guidelines on obesity treatment and the evolution of anti-obesity medications over the last decade.
Advertisement
Episodes in this series
1:20 Obesity-associated metabolic disturbances
5:37 When to start medication for obesity
8:28 Metabolic pathways leading to weight gain
13:19 Long-term impact of weight fluctuations
16:07 GLP-1 agonists for weight loss
20:26 Insurance coverage for anti-obesity medications (AOMs)
24:50 Combining lifestyle changes with AOMs
26:27 ‘Super-responders’ to GLP-1 agonist therapies
30:51 Non-responders to GLP-1 agonist therapies
37:28 Comprehensive approach to weight management
Advertisement
Related to this article
Stay updated with the latest healthcare breakthroughs, including new TRANSCEND-T2D-2 data and FDA actions.
Advertisement
Advertisement
Trending on HCPLive
1
Real-World Resmetirom Data Show Liver Stiffness Gains in MASH
2
IDEAL: Seladelpar Achieves ALP Normalization in Second-Line PBC
3
Conference Preview: 2026 GOLD International COPD Conference
4
Oral STAT6 Degrader KT-621 Reduces EASI by 62.6% in Atopic Dermatitis
5